MUTANTS OF EPSTEIN-BARR VIRUS
MUTANTS OF EPSTEIN-BARR VIRUS
批准号:
3197036
负责人:
I. GEORGE MILLER
金额:
$15.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-07-01 至 1995-06-30
关键词:
Epstein Barr virus cells gene expression genetic manipulation genetic markers genetic recombination genetic regulatory element genetic transcription lymphocyte molecular cloning mutant neoplastic cell nucleic acid hybridization plasmids tissue /cell culture transfection viral leukemogenesis virus DNA virus genetics virus receptors virus replication western blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The overall objective of experiments outlined in this proposal is to
develop methods for generating EBV mutant viruses. Only through
construction and analysis of such mutants will it eventually become clear
which EBV genes are essential for the process of lymphoid cell
immortalization, epithelial cell transformation, and oncogenesis. The
experiments rely on three different approaches. In the first approach
naturally occurring evolutionary variants will be characterized which
affect the entry pathway from latency into viral replication in
lymphocytes. Several new variants which affect genome size, configuration,
and the structure of orilyt are in hand. These will be studied in detail.
The second approach will attempt to take advantage of newly created cell
lines which have a virus receptor and are also permissive for virus
replication. These cells will be the substrate for recombination between
EBV strains or between subgenomic DNA fragments of one strain and another
complete genome. The third approach, for which we have the most preliminary
data, explores the use of recombinogenic cassettes in which a selectable
marker (for drug resistance) is flanked by EBV sequences, The objective is
to perfect a general method of EBV mutagenesis by homologous recombination
in which EBV genes are inactivated by insertion of a selectable marker. The
proposed experiments are based on combined biologic and genetic approaches
which should eventually increase our understanding of how EBV genes and
gene products interact to produce such diverse pathologic outcomes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biology of the Epstein-Barr Virus R Transactivator in Human B Cells
-
批准号:8307753
-
项目类别:
-
资助金额:$40.67万
-
财政年份:2011
-
负责人:I. GEORGE MILLER
-
依托单位:
Biology of the Epstein-Barr Virus R Transactivator in Human B Cells
-
批准号:7726047
-
项目类别:
-
资助金额:$40.78万
-
财政年份:2009
-
负责人:I. GEORGE MILLER
-
依托单位:
Project 1, Miller: Novel Functions of the Epstein-Barr Viral Lytic Cycle Activator Protein ZEBRA
-
批准号:8933100
-
项目类别:
-
资助金额:$19.8万
-
财政年份:1997
-
负责人:I. GEORGE MILLER
-
依托单位:
AIDS LYMPHOMA HARBORING TWO GAMMA HERPESVIRUSES
-
批准号:2113989
-
项目类别:
-
资助金额:$26.07万
-
财政年份:1995
-
负责人:I. GEORGE MILLER
-
依托单位:
AIDS LYMPHOMA HARBORING TWO GAMMA HERPESVIRUSES
-
批准号:2458234
-
项目类别:
-
资助金额:$30.33万
-
财政年份:1995
-
负责人:I. GEORGE MILLER
-
依托单位:
ACTIVATION OF KAPOSI SARCOMA-ASSOCIATED HERPES VIRUS
-
批准号:6376221
-
项目类别:
-
资助金额:$34.23万
-
财政年份:1995
-
负责人:I. GEORGE MILLER
-
依托单位:
ACTIVATION OF KAPOSI SARCOMA-ASSOCIATED HERPES VIRUS
-
批准号:6512813
-
项目类别:
-
资助金额:$34.73万
-
财政年份:1995
-
负责人:I. GEORGE MILLER
-
依托单位:
ACTIVATION OF KAPOSI SARCOMA-ASSOCIATED HERPES VIRUS
-
批准号:6173119
-
项目类别:
-
资助金额:$33.7万
-
财政年份:1995
-
负责人:I. GEORGE MILLER
-
依托单位:
AIDS LYMPHOMA HARBORING TWO GAMMA HERPESVIRUSES
-
批准号:2113991
-
项目类别:
-
资助金额:$26.94万
-
财政年份:1995
-
负责人:I. GEORGE MILLER
-
依托单位:
AIDS LYMPHOMA HARBORING TWO GAMMA HERPESVIRUSES
-
批准号:2800103
-
项目类别:
-
资助金额:$2.45万
-
财政年份:1995
-
负责人:I. GEORGE MILLER
-
依托单位:
ACTIVATION OF KAPOSI SARCOMA-ASSOCIATED HERPES VIRUS
-
批准号:6633104
-
项目类别:
-
资助金额:$35.59万
-
财政年份:1995
-
负责人:I. GEORGE MILLER
-
依托单位:
AIDS LYMPHOMA--HARBORING TWO GAMMA HERPESVIRUSES
-
批准号:2520274
-
项目类别:
-
资助金额:$2.48万
-
财政年份:1995
-
负责人:I. GEORGE MILLER
-
依托单位:
ACTIVATION OF KAPOSI SARCOMA ASSOCIATED HERPES VIRUS
-
批准号:6016912
-
项目类别:
-
资助金额:$29.0万
-
财政年份:1995
-
负责人:I. GEORGE MILLER
-
依托单位:
MUTANTS OF EPSTEIN-BARR VIRUS
-
批准号:3197038
-
项目类别:
-
资助金额:$23.3万
-
财政年份:1990
-
负责人:I. GEORGE MILLER
-
依托单位:
MUTANTS OF EPSTEIN BARR VIRUS
-
批准号:2094648
-
项目类别:
-
资助金额:$24.11万
-
财政年份:1990
-
负责人:I. GEORGE MILLER
-
依托单位:
MUTANTS OF EPSTEIN-BARR VIRUS
-
批准号:3197039
-
项目类别:
-
资助金额:$23.42万
-
财政年份:1990
-
负责人:I. GEORGE MILLER
-
依托单位:
MUTANTS OF EPSTEIN-BARR VIRUS
-
批准号:3197037
-
项目类别:
-
资助金额:$20.74万
-
财政年份:1990
-
负责人:I. GEORGE MILLER
-
依托单位:
PATHOGENESIS OF EPSTEIN BARR VIRUS INFECTIONS
-
批准号:2062041
-
项目类别:
-
资助金额:$35.94万
-
财政年份:1986
-
负责人:I. GEORGE MILLER
-
依托单位:
PATHOGENESIS OF EPSTEIN-BARR VIRUS INFECTIONS
-
批准号:3481221
-
项目类别:
-
资助金额:$27.91万
-
财政年份:1986
-
负责人:I. GEORGE MILLER
-
依托单位:
PATHOGENESIS OF EPSTEIN BARR VIRUS INFECTIONS
-
批准号:2062042
-
项目类别:
-
资助金额:$12.0万
-
财政年份:1986
-
负责人:I. GEORGE MILLER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: